Brain Cancer Trial, Recruiting (NCT06320496)

Brain Cancer Trial, Recruiting NCT06320496 Sponsor: Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06320496 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children who have a chronic condition, rare disease, or disability that has led to a reduced ability to exercise
Children who are attending the CMPRE centre for a program focused on returning to physical activity

Who may not be able to join:

Children who are younger than 8 years old or older than 18 years old
Patients who are receiving rehabilitation treatment during the stay
Patients whose medical treatment or care plan changes significantly during the stay
Patients who have significant cognitive difficulties that prevent them from understanding instructions
Patients who are already regularly active in a sports club or leisure activity three or more times per week
Patients who use an electric wheelchair
Patients who miss a significant amount of the stay (5½ days or more out of the total time)
Patients who are already taking part in another research study during the return-to-physical-activity stay

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 3 82 52 6761

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06320496

Sponsor: Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est

Phase: Not Applicable

Status: Recruiting

Condition: Brain Cancer

Trial contact: +33 3 82 52 6761

More information: https://clinicaltrials.gov/study/NCT06320496

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children who have a chronic condition, rare disease, or disability that has led to a reduced ability to exercise
Children who are attending the CMPRE centre for a program focused on returning to physical activity

Who may not be able to join:

Children who are younger than 8 years old or older than 18 years old
Patients who are receiving rehabilitation treatment during the stay
Patients whose medical treatment or care plan changes significantly during the stay
Patients who have significant cognitive difficulties that prevent them from understanding instructions
Patients who are already regularly active in a sports club or leisure activity three or more times per week
Patients who use an electric wheelchair
Patients who miss a significant amount of the stay (5½ days or more out of the total time)
Patients who are already taking part in another research study during the return-to-physical-activity stay

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est

Registry

ClinicalTrials.gov

Start date

22 March 2022

Est. completion

1 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Diagnoform test score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov